Smith & Nephew plc ADR Stock
Smith & Nephew plc ADR Stock
Smith & Nephew plc ADR took a tumble today and lost -€2.000 (-7.140%).
Pros and Cons of Smith & Nephew plc ADR in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
B****
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Smith & Nephew plc ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Smith & Nephew plc ADR | -7.140% | 2.190% | 4.478% | 4.478% | 0.000% | 8.527% | -15.152% |
| Smith & Nephew plc | -1.520% | -8.333% | -1.493% | -1.529% | -7.140% | 1.695% | -19.879% |
| Humana Inc. | 1.270% | -8.187% | -9.770% | 46.935% | 42.987% | -28.636% | -12.802% |
| Agilent Technologies Inc. | -0.330% | -0.453% | 5.736% | 21.577% | 3.011% | 5.229% | -7.329% |
Comments
Smith & Nephew SNATS (SNN) had its "buy" rating reaffirmed by The Goldman Sachs Group, Inc..
Show more
Ratings data for SNN provided by MarketBeat
Smith & Nephew SNATS (SNN) was upgraded by Wall Street Zen from "buy" to "strong-buy".
Show more
Ratings data for SNN provided by MarketBeat
Smith & Nephew SNATS (NYSE:SNN) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for SNN provided by MarketBeat